<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35887167</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>14</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Role and Therapeutic Potential of the Integrated Stress Response in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7823</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23147823</ELocationID><Abstract><AbstractText>In amyotrophic lateral sclerosis (ALS) patients, loss of cellular homeostasis within cortical and spinal cord motor neurons triggers the activation of the integrated stress response (ISR), an intracellular signaling pathway that remodels translation and promotes a gene expression program aimed at coping with stress. Beyond its neuroprotective role, under regimes of chronic or excessive stress, ISR can also promote cell/neuronal death. Given the two-edged sword nature of ISR, many experimental attempts have tried to establish the therapeutic potential of ISR enhancement or inhibition in ALS. This review discusses the complex interplay between ISR and disease progression in different models of ALS, as well as the opportunities and limitations of ISR modulation in the hard quest to find an effective therapy for ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marlin</LastName><ForeName>El&#xed;as</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0727-2554</Identifier><AffiliationInfo><Affiliation>Neuroscience Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gene Therapy and Regulation of Gene Expression Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Navarra, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Department, Navarra Institute for Health Research (IdiSNA), University of Navarra, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viu-Idocin</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Sciences, University of Navarra, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arrasate</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8911-8990</Identifier><AffiliationInfo><Affiliation>Neuroscience Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Navarra, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Department, Navarra Institute for Health Research (IdiSNA), University of Navarra, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arag&#xf3;n</LastName><ForeName>Tom&#xe1;s</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Gene Therapy and Regulation of Gene Expression Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Department, Navarra Institute for Health Research (IdiSNA), University of Navarra, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PID2020-120497RB-I00</GrantID><Agency>MCIN/AEI/10.13039/501100011033</Agency><Country/></Grant><Grant><GrantID>0011-0537-2018-000006</GrantID><Agency>Predoctoral Fellowship Gobierno de Navarra</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS clinical trials</Keyword><Keyword MajorTopicYN="N">ALS experimental models</Keyword><Keyword MajorTopicYN="N">RNA-binding proteins</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">integrated stress response</Keyword><Keyword MajorTopicYN="N">translation</Keyword><Keyword MajorTopicYN="N">uORFs-containing mRNAs</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35887167</ArticleId><ArticleId IdType="pmc">PMC9321386</ArticleId><ArticleId IdType="doi">10.3390/ijms23147823</ArticleId><ArticleId IdType="pii">ijms23147823</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthur K.C., Calvo A., Price T.R., Geiger J.T., Chi&#xf2; A., Traynor B.J. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat. Commun. 2016;7:12408. doi: 10.1038/ncomms12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman M., Zinman L. The economic impact of amyotrophic lateral sclerosis: A systematic review. Expert Rev. Pharmacoecon. Outcomes Res. 2015;15:439&#x2013;450. doi: 10.1586/14737167.2015.1039941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737167.2015.1039941</ArticleId><ArticleId IdType="pubmed">25924979</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nfelder E., Osmanovic A., M&#xfc;schen L.H., Petri S., Schreiber-Katz O. Costs of illness in amyotrophic lateral sclerosis (ALS): A cross-sectional survey in Germany. Orphanet J. Rare Dis. 2020;15:149. doi: 10.1186/s13023-020-01413-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-020-01413-9</ArticleId><ArticleId IdType="pmc">PMC7291655</ArticleId><ArticleId IdType="pubmed">32532288</ArticleId></ArticleIdList></Reference><Reference><Citation>Edaravone Acute Infarction Study Group Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc. Dis. 2003;15:222&#x2013;229. doi: 10.1159/000069318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000069318</ArticleId><ArticleId IdType="pubmed">12715790</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA Approves Drug to Treat ALS.  [(accessed on 11 July 2022)]; Available online:  https://www.fda.gov/news-events/press-announcements/fda-approves-drug-treat-als.</Citation></Reference><Reference><Citation>Breiner A., Zinman L., Bourque P.R. Edaravone for amyotrophic lateral sclerosis: Barriers to access and lifeboat ethics. CMAJ. 2020;192:E319&#x2013;E320. doi: 10.1503/cmaj.191236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.191236</ArticleId><ArticleId IdType="pmc">PMC7101182</ArticleId><ArticleId IdType="pubmed">32392516</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Aoki M., Tsuji S., Itoyama Y., Sobue G., Togo M., Hamada C., Tanaka M., Akimoto M., Nakamura K., et al. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanabe M., Corporation P., Head M., Osaka O.  Withdrawal of Marketing Authorization Application of Edaravone for ALS in the European Union. Mitsubishi Tanabe Pharma. Europe Ltd.; London, UK: 2019.  [(accessed on 11 July 2022)]. pp. 1&#x2013;2. Available online:  https://www.mt-pharma.co.jp/e/news/assets/pdf/e_MTPC190530.pdf.</Citation></Reference><Reference><Citation>FDA Approves Oral Form for the Treatment of Adults with Amyotrophic Lateral Sclerosis (ALS)  [(accessed on 11 July 2022)]; Available online:  https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-oral-form-treatment-adults-amyotrophic-lateral-sclerosis-als.</Citation></Reference><Reference><Citation>Charcot J.-M., Joffroy A. Deux cas d&#x2019;atrophie musculaire progressive avec l&#xe9;sions de la substance grise et des faiseaux ant&#xe9;ro-lat&#xe9;raux de la moelle &#xe9;pini&#xe8;re. Arch. Physiol. Norm. Pathol. 1869;2:744&#x2013;760.</Citation></Reference><Reference><Citation>Siddique T., Figlewigz D.A., Pericak-Vance M.A., Haines J.L., Rouleau G., Jeffers A.J., Sapp P., Hung W.-Y., Bebout J., McKenna-Yasek D., et al. Linkage of a Gene Causing Familial Amyotrophic Lateral Sclerosis to Chromosome 21 and Evidence of Genetic-Locus Heterogeneity. N. Engl. J. Med. 1991;324:1381&#x2013;1384. doi: 10.1056/NEJM199105163242001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199105163242001</ArticleId><ArticleId IdType="pubmed">2020294</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362. doi: 10.1038/364362c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364362c0</ArticleId><ArticleId IdType="pubmed">8332197</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.X., Xu H.F., Wang P.S., Yang X.X., Wu Z.Y., Li H.F. SOD1 Mutation Spectrum and Natural History of ALS Patients in a 15-Year Cohort in Southeastern China. Front. Genet. 2021;12:1891. doi: 10.3389/fgene.2021.746060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.746060</ArticleId><ArticleId IdType="pmc">PMC8551486</ArticleId><ArticleId IdType="pubmed">34721532</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: What do we really know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller K., Oh K.W., Nordin A., Panthi S., Kim S.H., Nordin F., Freischmidt A., Ludolph A.C., Ki C.S., Forsberg K., et al. De novo mutations in SOD1 are a cause of ALS. J. Neurol. Neurosurg. Psychiatry. 2022;93:201&#x2013;206. doi: 10.1136/jnnp-2021-327520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327520</ArticleId><ArticleId IdType="pmc">PMC8784989</ArticleId><ArticleId IdType="pubmed">34518333</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E., Renton A.E., Mok K., Dopper E.G.P., Waite A., Rollinson S., Chi&#xf2; A., Restagno G., Nicolaou N., Simon-Sanchez J., et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study. Lancet. Neurol. 2012;11:323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Bieniek K.F., Zhang Y.J., Jansen-West K., Ash P.E.A., Caulfield T., Daughrity L., Dunmore J.H., Castanedes-Casey M., Chew J., et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126:829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gronke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O., Pietrzyk J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Tan W., Westergard T., Krishnamurthy K., Markandaiah S.S., Shi Y., Lin S., Shneider N.A., Monaghan G., Pandey U.B., et al. Antisense Proline-Arginine RAN Dipeptides Linked to C9ORF72-ALS/FTD Form Toxic Nuclear Aggregates that Initiate In Vitro and In Vivo Neuronal Death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd T.W., McEachin Z.T., Chew J., Burch A.R., Jansen-West K., Tong J., Yue M., Song Y., Castanedes-Casey M., Kurti A., et al. Hexanucleotide Repeat Expansions in c9FTD/ALS and SCA36 Confer Selective Patterns of Neurodegeneration In Vivo. Cell Rep. 2020;31:107616. doi: 10.1016/j.celrep.2020.107616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107616</ArticleId><ArticleId IdType="pmc">PMC7480900</ArticleId><ArticleId IdType="pubmed">32375043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C.J., Haeusler A.R., Grima J.C., Machamer J.B., Steinwald P., Daley E.L., Miller S.J., Cunningham K.M., Vidensky S., et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.H., Badders N., Valentine M., Miller B.L., Wong P.C., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x10d; A., Mertens J., Boeynaems S., Bogaert E., Chai N., Yamada S.B., Paul J.W., Sun S., Herdy J.R., Bieri G., et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 2015;18:1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Arzberger T., Schludi M.H., Lehmer C., Schmid B., Edbauer D. RNA versus protein toxicity in C9orf72 ALS/FTLD. Acta Neuropathol. 2018;135:475&#x2013;479. doi: 10.1007/s00401-018-1823-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1823-1</ArticleId><ArticleId IdType="pubmed">29450647</ArticleId></ArticleIdList></Reference><Reference><Citation>Frottin F., P&#xe9;rez-Berlanga M., Hartl F.U., Hipp M.S. Multiple pathways of toxicity induced by c9orf72 dipeptide repeat aggregates and g4c2 rna in a cellular model. eLife. 2021;10:e62718. doi: 10.7554/eLife.62718.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.62718</ArticleId><ArticleId IdType="pmc">PMC8221807</ArticleId><ArticleId IdType="pubmed">34161229</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Shu S., Wang R.R., Liu F., Cui B., Guo X.N., Lu C.X., Li X.G., Liu M.S., Peng B., et al. Whole-exome sequencing identifies a missense mutation in hnRNPA1 in a family with flail arm ALS. Neurology. 2016;87:1763&#x2013;1769. doi: 10.1212/WNL.0000000000003256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003256</ArticleId><ArticleId IdType="pubmed">27694260</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Sayana P., Zhang X., Le W. Genetics of amyotrophic lateral sclerosis: An update. Mol. Neurodegener. 2013;8:28. doi: 10.1186/1750-1326-8-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nat. Rev. Neurosci. 2006;7:710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S., Ait-El-Mkadem S., Chaussenot A., Genin E.C., Lacas-Gervais S., Fragaki K., Berg-Alonso L., Kageyama Y., Serre V., Moore D.G., et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137:2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L., Van Damme P., Bogaert E., Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta-Mol. Basis Dis. 2006;1762:1068&#x2013;1082. doi: 10.1016/j.bbadis.2006.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.05.002</ArticleId><ArticleId IdType="pubmed">16806844</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mart&#xed;nez-Silva M.L., Imhoff-Manuel R.D., Sharma A., Heckman C.J., Shneider N.A., Roselli F., Zytnicki D., Manuel M. Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS. eLife. 2018;7:e30955. doi: 10.7554/eLife.30955.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.30955</ArticleId><ArticleId IdType="pmc">PMC5922970</ArticleId><ArticleId IdType="pubmed">29580378</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa-Mattioli M., Walter P. The integrated stress response: From mechanism to disease. Science. 2020;368:eaat5314. doi: 10.1126/science.aat5314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat5314</ArticleId><ArticleId IdType="pmc">PMC8997189</ArticleId><ArticleId IdType="pubmed">32327570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapur M., Monaghan C.E., Ackerman S.L. Regulation of mRNA Translation in Neurons&#x2014;A Matter of Life and Death. Neuron. 2017;96:616&#x2013;637. doi: 10.1016/j.neuron.2017.09.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.09.057</ArticleId><ArticleId IdType="pmc">PMC5693308</ArticleId><ArticleId IdType="pubmed">29096076</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesnokova E., Bal N., Kolosov P. Kinases of eIF2a Switch Translation of mRNA Subset during Neuronal Plasticity. Int. J. Mol. Sci. 2017;18:2213. doi: 10.3390/ijms18102213.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102213</ArticleId><ArticleId IdType="pmc">PMC5666893</ArticleId><ArticleId IdType="pubmed">29065505</ArticleId></ArticleIdList></Reference><Reference><Citation>English A.M., Green K.M., Moon S.L. A (dis)integrated stress response: Genetic diseases of eIF2&#x3b1; regulators. Wiley Interdiscip. Rev. RNA. 2022;13:e1689. doi: 10.1002/wrna.1689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1689</ArticleId><ArticleId IdType="pubmed">34463036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimura R., Nagy G., Dotu I., Chuang J.H., Ackerman S.L. Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation. eLife. 2016;5:e14295. doi: 10.7554/eLife.14295.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.14295</ArticleId><ArticleId IdType="pmc">PMC4917338</ArticleId><ArticleId IdType="pubmed">27085088</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaulding E.L., Hines T.J., Bais P., Tadenev A.L.D., Schneider R., Jewett D., Pattavina B., Pratt S.L., Morelli K.H., Stum M.G., et al. The integrated stress response contributes to tRNA synthetase&#x2013;associated peripheral neuropathy. Science. 2021;373:1156&#x2013;1161. doi: 10.1126/science.abb3414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3414</ArticleId><ArticleId IdType="pmc">PMC8908546</ArticleId><ArticleId IdType="pubmed">34516839</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T., Trinh M.A., Wexler A.J., Bourbon C., Gatti E., Pierre P., Cavener D.R., Klann E. Suppression of eIF2&#x3b1; kinases alleviates Alzheimer&#x2019;s disease-related plasticity and memory deficits. Nat. Neurosci. 2013;16:1299&#x2013;1305. doi: 10.1038/nn.3486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3486</ArticleId><ArticleId IdType="pmc">PMC3756900</ArticleId><ArticleId IdType="pubmed">23933749</ArticleId></ArticleIdList></Reference><Reference><Citation>Devi L., Ohno M. Deletion of the eIF2&#x3b1; Kinase GCN2 Fails to Rescue the Memory Decline Associated with Alzheimer&#x2019;s Disease. PLoS ONE. 2013;8:e77335. doi: 10.1371/journal.pone.0077335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077335</ArticleId><ArticleId IdType="pmc">PMC3795630</ArticleId><ArticleId IdType="pubmed">24146979</ArticleId></ArticleIdList></Reference><Reference><Citation>Han A.P., Yu C., Lu L., Fujiwara Y., Browne C., Chin G., Fleming M., Leboulch P., Orkin S.H., Chen J.J. Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO J. 2001;20:6909&#x2013;6918. doi: 10.1093/emboj/20.23.6909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.23.6909</ArticleId><ArticleId IdType="pmc">PMC125753</ArticleId><ArticleId IdType="pubmed">11726526</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.-J., Zhang S. Translational control by heme-regulated elF2&#x3b1; kinase during erythropoiesis. Curr. Opin. Hematol. 2022;29:103&#x2013;111. doi: 10.1097/MOH.0000000000000704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0000000000000704</ArticleId><ArticleId IdType="pmc">PMC9154293</ArticleId><ArticleId IdType="pubmed">35441596</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Castelao B., Tom Dieck S., Fusco C.M., Donlin-Asp P., Perez J.D., Schuman E.M. The switch-like expression of heme-regulated kinase 1 mediates neuronal proteostasis following proteasome inhibition. eLife. 2020;9:e52714. doi: 10.7554/eLife.52714.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.52714</ArticleId><ArticleId IdType="pmc">PMC7224698</ArticleId><ArticleId IdType="pubmed">32329716</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee T., Ramaglia V., Abdel-Nour M., Bianchi A.A., Tsalikis J., Chau H.N., Kalia S.K., Kalia L.V., Chen J.J., Arnoult D., et al. The eIF2&#x3b1; kinase HRI triggers the autophagic clearance of cytosolic protein aggregates. J. Biol. Chem. 2020;296:100050. doi: 10.1074/jbc.RA120.014415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.014415</ArticleId><ArticleId IdType="pmc">PMC7948985</ArticleId><ArticleId IdType="pubmed">33168630</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Nour M., Carneiro L.A.M., Downey J., Tsalikis J., Outlioua A., Prescott D., Da Costa L.S., Hovingh E.S., Farahvash A., Gaudet R.G., et al. The heme-regulated inhibitor is a cytosolic sensor of protein misfolding that controls innate immune signaling. Science. 2019;365:eaaw4144. doi: 10.1126/science.aaw4144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw4144</ArticleId><ArticleId IdType="pubmed">31273097</ArticleId></ArticleIdList></Reference><Reference><Citation>Fessler E., Eckl E.M., Schmitt S., Mancilla I.A., Meyer-Bender M.F., Hanf M., Philippou-Massier J., Krebs S., Zischka H., Jae L.T. A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol. Nature. 2020;579:433&#x2013;437. doi: 10.1038/s41586-020-2076-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2076-4</ArticleId><ArticleId IdType="pmc">PMC7116715</ArticleId><ArticleId IdType="pubmed">32132706</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Aviles G., Liu Y., Tian R., Unger B.A., Lin Y.H.T., Wiita A.P., Xu K., Correia M.A., Kampmann M. Mitochondrial stress is relayed to the cytosol by an OMA1&#x2013;DELE1&#x2013;HRI pathway. Nature. 2020;579:427&#x2013;432. doi: 10.1038/s41586-020-2078-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2078-2</ArticleId><ArticleId IdType="pmc">PMC7147832</ArticleId><ArticleId IdType="pubmed">32132707</ArticleId></ArticleIdList></Reference><Reference><Citation>Quir&#xf3;s P.M., Prado M.A., Zamboni N., D&#x2019;Amico D., Williams R.W., Finley D., Gygi S.P., Auwerx J. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals. J. Cell Biol. 2017;216:2027&#x2013;2045. doi: 10.1083/jcb.201702058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201702058</ArticleId><ArticleId IdType="pmc">PMC5496626</ArticleId><ArticleId IdType="pubmed">28566324</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel S., Canonne M., Arnould T., Renard P. Inhibition of mitochondrial genome expression triggers the activation of CHOP-10 by a cell signaling dependent on the integrated stress response but not the mitochondrial unfolded protein response. Mitochondrion. 2015;21:58&#x2013;68. doi: 10.1016/j.mito.2015.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2015.01.005</ArticleId><ArticleId IdType="pubmed">25643991</ArticleId></ArticleIdList></Reference><Reference><Citation>Balsa E., Soustek M.S., Thomas A., Cogliati S., Garc&#xed;a-Poyatos C., Mart&#xed;n-Garc&#xed;a E., Jedrychowski M., Gygi S.P., Enriquez J.A., Puigserver P. ER and Nutrient Stress Promote Assembly of Respiratory Chain Supercomplexes through the PERK-eIF2&#x3b1; Axis. Mol. Cell. 2019;74:877&#x2013;890.e6. doi: 10.1016/j.molcel.2019.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.03.031</ArticleId><ArticleId IdType="pmc">PMC6555668</ArticleId><ArticleId IdType="pubmed">31023583</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez E., Powell M.L., Bevington A., Herbert T.P. A decrease in cellular energy status stimulates PERK-dependent eIF2alpha phosphorylation and regulates protein synthesis in pancreatic beta-cells. Biochem. J. 2008;410:485&#x2013;493. doi: 10.1042/BJ20071367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20071367</ArticleId><ArticleId IdType="pubmed">18052927</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniuchi S., Miyake M., Tsugawa K., Oyadomari M., Oyadomari S. Integrated stress response of vertebrates is regulated by four eIF2&#x3b1; kinases. Sci. Rep. 2016;6:32886. doi: 10.1038/srep32886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep32886</ArticleId><ArticleId IdType="pmc">PMC5025754</ArticleId><ArticleId IdType="pubmed">27633668</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovanessian A.G. On the discovery of interferon-inducible, double-stranded RNA activated enzymes: The 2&#x2019;-5&#x2032;oligoadenylate synthetases and the protein kinase PKR. Cytokine Growth Factor Rev. 2007;18:351&#x2013;361. doi: 10.1016/j.cytogfr.2007.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2007.06.003</ArticleId><ArticleId IdType="pubmed">17681872</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef O.A., Safran S.A., Nakamura T., Nix D.A., Hotamisligil G.S., Bass B.L. Potential role for snoRNAs in PKR activation during metabolic stress. Proc. Natl. Acad. Sci. USA. 2015;112:5023&#x2013;5028. doi: 10.1073/pnas.1424044112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1424044112</ArticleId><ArticleId IdType="pmc">PMC4413318</ArticleId><ArticleId IdType="pubmed">25848059</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Park J., Kim S., Kim M.A., Kang M.G., Kwak C., Kang M., Kim B., Rhee H.W., Kim V.N. PKR Senses Nuclear and Mitochondrial Signals by Interacting with Endogenous Double-Stranded RNAs. Mol. Cell. 2018;71:1051&#x2013;1063.e6. doi: 10.1016/j.molcel.2018.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.029</ArticleId><ArticleId IdType="pubmed">30174290</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano P.R., Garcia-Barrio M.T., Zhang X., Wang Q., Taylor D.R., Zhang F., Herring C., Mathews M.B., Qin J., Hinnebusch A.G. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol. Cell. Biol. 1998;18:2282&#x2013;2297. doi: 10.1128/MCB.18.4.2282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.18.4.2282</ArticleId><ArticleId IdType="pmc">PMC121479</ArticleId><ArticleId IdType="pubmed">9528799</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao H., Jiang T., Mu P., Chen X., Wen X., Hu Z., Tang S., Wen J., Deng Y. Cell fate determined by the activation balance between PKR and SPHK1. Cell Death Differ. 2021;28:401&#x2013;418. doi: 10.1038/s41418-020-00608-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00608-8</ArticleId><ArticleId IdType="pmc">PMC7852545</ArticleId><ArticleId IdType="pubmed">32801355</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel R.C., Sen G.C. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 1998;17:4379&#x2013;4390. doi: 10.1093/emboj/17.15.4379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/17.15.4379</ArticleId><ArticleId IdType="pmc">PMC1170771</ArticleId><ArticleId IdType="pubmed">9687506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito T., Yang M., May W.S. RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J. Biol. Chem. 1999;274:15427&#x2013;15432. doi: 10.1074/jbc.274.22.15427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.22.15427</ArticleId><ArticleId IdType="pubmed">10336432</ArticleId></ArticleIdList></Reference><Reference><Citation>Deb A., Haque S.J., Mogensen T., Silverman R.H., Williams B.R. RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway. J. Immunol. 2001;166:6170&#x2013;6180. doi: 10.4049/jimmunol.166.10.6170.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.10.6170</ArticleId><ArticleId IdType="pubmed">11342638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaempfer R., Namer L.S., Osman F., Ilan L. Control of mRNA splicing by noncoding intragenic RNA elements that evoke a cellular stress response. Int. J. Biochem. Cell Biol. 2018;105:20&#x2013;23. doi: 10.1016/j.biocel.2018.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2018.09.021</ArticleId><ArticleId IdType="pubmed">30282053</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H., van Beers E.J. Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias. Ther. Adv. Hematol. 2021;12:20406207211066070. doi: 10.1177/20406207211066070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406207211066070</ArticleId><ArticleId IdType="pmc">PMC8721383</ArticleId><ArticleId IdType="pubmed">34987744</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter P., Ron D. The unfolded protein response: From stress pathway to homeostatic regulation. Science. 2011;334:1081&#x2013;1086. doi: 10.1126/science.1209038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1209038</ArticleId><ArticleId IdType="pubmed">22116877</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollien J., Weissman J.S. Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science. 2006;313:104&#x2013;107. doi: 10.1126/science.1129631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1129631</ArticleId><ArticleId IdType="pubmed">16825573</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullinan S.B., Zhang D., Hannink M., Arvisais E., Kaufman R.J., Diehl J.A. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol. 2003;23:7198&#x2013;7209. doi: 10.1128/MCB.23.20.7198-7209.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.23.20.7198-7209.2003</ArticleId><ArticleId IdType="pmc">PMC230321</ArticleId><ArticleId IdType="pubmed">14517290</ArticleId></ArticleIdList></Reference><Reference><Citation>van Vliet A.R., Giordano F., Gerlo S., Segura I., Van Eygen S., Molenberghs G., Rocha S., Houcine A., Derua R., Verfaillie T., et al. The ER Stress Sensor PERK Coordinates ER-Plasma Membrane Contact Site Formation through Interaction with Filamin-A and F-Actin Remodeling. Mol. Cell. 2017;65:885&#x2013;899.e6. doi: 10.1016/j.molcel.2017.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.01.020</ArticleId><ArticleId IdType="pubmed">28238652</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C., Saxena S. ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol. 2017;13:477&#x2013;491. doi: 10.1038/nrneurol.2017.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.99</ArticleId><ArticleId IdType="pubmed">28731040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva E.V., Ayala V., Jove M., Dalfo E., Cacabelos D., Povedano M., Bellmunt M.J., Ferrer I., Pamplona R., Portero-Otin M. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain. 2007;130:3111&#x2013;3123. doi: 10.1093/brain/awm190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm190</ArticleId><ArticleId IdType="pubmed">17716997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C., Thielen P., Matus S., Nassif M., Court F., Kiffin R., Martinez G., Cuervo A.M., Brown R.H., Glimcher L.H. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 2009;23:2294&#x2013;2306. doi: 10.1101/gad.1830709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1830709</ArticleId><ArticleId IdType="pmc">PMC2758741</ArticleId><ArticleId IdType="pubmed">19762508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y., Yamada M., Tanaka H., Aida K., Tsuruma K., Shimazawa M., Hozumi I., Inuzuka T., Takahashi H., Hara H. Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice. Neurobiol. Dis. 2009;36:470&#x2013;476. doi: 10.1016/j.nbd.2009.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.08.013</ArticleId><ArticleId IdType="pubmed">19733664</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Farg M.A., Bye C.R., McLean C.A., Horne M.K., Atkin J.D. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis. Brain. 2010;133:105&#x2013;116. doi: 10.1093/brain/awp267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp267</ArticleId><ArticleId IdType="pubmed">19903735</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheper W., Hoozemans J.J. The unfolded protein response in neurodegenerative diseases: A neuropathological perspective. Acta Neuropathol. 2015;130:315&#x2013;331. doi: 10.1007/s00401-015-1462-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1462-8</ArticleId><ArticleId IdType="pmc">PMC4541706</ArticleId><ArticleId IdType="pubmed">26210990</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S. Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2010;69:346&#x2013;355. doi: 10.1097/NEN.0b013e3181d44992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181d44992</ArticleId><ArticleId IdType="pubmed">20448480</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyanagi K., Yamazaki M., Takahashi H., Watabe K., Wada M., Komori T., Morita T., Mizutani T. Spinal anterior horn cells in sporadic amyotrophic lateral sclerosis show ribosomal detachment from, and cisternal distention of the rough endoplasmic reticulum. Neuropathol. Appl. Neurobiol. 2008;34:650&#x2013;658. doi: 10.1111/j.1365-2990.2008.00941.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2008.00941.x</ArticleId><ArticleId IdType="pubmed">18346115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E., Sandoe J., Williams L.A., Boulting G.L., Moccia R., Wainger B.J., Han S., Peng T., Thams S., Mikkilineni S., et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14:781&#x2013;795. doi: 10.1016/j.stem.2014.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.03.004</ArticleId><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Perciballi E., Bovio F., Rosati J., Arrigoni F., D&#x2019;Anzi A., Lattante S., Gelati M., De Marchi F., Lombardi I., Ruotolo G., et al. Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients. Antioxidants. 2022;11:815. doi: 10.3390/antiox11050815.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11050815</ArticleId><ArticleId IdType="pmc">PMC9137766</ArticleId><ArticleId IdType="pubmed">35624679</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub I.R., Weraarpachai W., Shoubridge E.A. Multi-OMICS study of a CHCHD10 variant causing ALS demonstrates metabolic rewiring and activation of endoplasmic reticulum and mitochondrial unfolded protein responses. Hum. Mol. Genet. 2021;30:687&#x2013;705. doi: 10.1093/hmg/ddab078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab078</ArticleId><ArticleId IdType="pmc">PMC8127406</ArticleId><ArticleId IdType="pubmed">33749723</ArticleId></ArticleIdList></Reference><Reference><Citation>Guber R.D., Schindler A.B., Budron M.S., Chen K.L., Li Y., Fischbeck K.H., Grunseich C. Nucleocytoplasmic transport defect in a North American patient with ALS8. Ann. Clin. Transl. Neurol. 2018;5:369&#x2013;375. doi: 10.1002/acn3.515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.515</ArticleId><ArticleId IdType="pmc">PMC5846449</ArticleId><ArticleId IdType="pubmed">29560381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Gumina V., Lenzi P., Bossolasco P., Fulceri F., Volpe C., Bardelli D., Pregnolato F., Maraschi A., Fornai F., et al. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiol. Dis. 2020;145:105051. doi: 10.1016/j.nbd.2020.105051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105051</ArticleId><ArticleId IdType="pubmed">32827688</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzi J., De Santis R., de Turris V., Morlando M., Laneve P., Calvo A., Caliendo V., Chi&#xf2; A., Rosa A., Bozzoni I. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons. Dis. Model. Mech. 2015;8:755&#x2013;766. doi: 10.1242/dmm.020099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.020099</ArticleId><ArticleId IdType="pmc">PMC4486861</ArticleId><ArticleId IdType="pubmed">26035390</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Lemay N., Ko H.K., Zhou H., Burke C., Kwiatkowski T.J.J., Sapp P., McKenna-Yasek D., Brown R.H.J., Hayward L.J. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 2010;19:4160&#x2013;4175. doi: 10.1093/hmg/ddq335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq335</ArticleId><ArticleId IdType="pmc">PMC2981014</ArticleId><ArticleId IdType="pubmed">20699327</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A.S.T., Chun C., Hesson J., Mathieu J., Valdmanis P.N., Mack D.L., Choi B.-O., Kim D.-H., Bothwell M. Human Induced Pluripotent Stem Cell-Derived TDP-43 Mutant Neurons Exhibit Consistent Functional Phenotypes Across Multiple Gene Edited Lines Despite Transcriptomic and Splicing Discrepancies. Front. cell Dev. Biol. 2021;9:728707. doi: 10.3389/fcell.2021.728707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.728707</ArticleId><ArticleId IdType="pmc">PMC8511491</ArticleId><ArticleId IdType="pubmed">34660586</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Zerbo R.A., Balbi M., Torazza C., Frumento G., Fedele E., Bonanno G., Milanese M. Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives. Int. J. Mol. Sci. 2021;22:12236. doi: 10.3390/ijms222212236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212236</ArticleId><ArticleId IdType="pmc">PMC8619465</ArticleId><ArticleId IdType="pubmed">34830115</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh H., Kadowaki H., Nagai A., Maruyama T., Yokota T., Fukutomi H., Noguchi T., Matsuzawa A., Takeda K., Ichijo H. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 2008;22:1451&#x2013;1464. doi: 10.1101/gad.1640108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1640108</ArticleId><ArticleId IdType="pmc">PMC2418582</ArticleId><ArticleId IdType="pubmed">18519638</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T., Lautenschl&#xe4;ger J., Witte O.W., Carri M.T., Grosskreutz J. The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis. Eur. J. Neurosci. 2012;35:652&#x2013;660. doi: 10.1111/j.1460-9568.2012.08008.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2012.08008.x</ArticleId><ArticleId IdType="pubmed">22390177</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Sun Y., Ling S.C., Ferraiuolo L., McAlonis-Downes M., Zou Y., Drenner K., Wang Y., Ditsworth D., Tokunaga S., et al. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proc. Natl. Acad. Sci. USA. 2015;112:E6993&#x2013;E7002. doi: 10.1073/pnas.1520639112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1520639112</ArticleId><ArticleId IdType="pmc">PMC4687558</ArticleId><ArticleId IdType="pubmed">26621731</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugallo R., Marlin E., Baltan&#xe1;s A., Toledo E., Ferrero R., Vinueza-Gavilanes R., Larrea L., Arrasate M., Arag&#xf3;n T. Fine tuning of the unfolded protein response by ISRIB improves neuronal survival in a model of amyotrophic lateral sclerosis. Cell Death Dis. 2020;11:397. doi: 10.1038/s41419-020-2601-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2601-2</ArticleId><ArticleId IdType="pmc">PMC7250913</ArticleId><ArticleId IdType="pubmed">32457286</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehvil&#xe4;inen P., Koistinaho J., Gundars G. Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2014;8:126. doi: 10.3389/fncel.2014.00126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00126</ArticleId><ArticleId IdType="pmc">PMC4023018</ArticleId><ArticleId IdType="pubmed">24847211</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S.J., McKeown S.R., Rashid S. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. Gene. 2016;577:109&#x2013;118. doi: 10.1016/j.gene.2015.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer N.J., Haney M.S., Morgens D.W., Jovi&#x10d;i&#x107; A., Couthouis J., Li A., Ousey J., Ma R., Bieri G., Tsui C.K., et al. CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nat. Genet. 2018;50:603&#x2013;612. doi: 10.1038/s41588-018-0070-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0070-7</ArticleId><ArticleId IdType="pmc">PMC5893388</ArticleId><ArticleId IdType="pubmed">29507424</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T., Guo S., Bardhi O., Ryskamp D.A., Li J., Khoramian Tusi S., Engelbrecht A., Klippel K., Chakrabarty P., Nguyen L., et al. Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice. Proc. Natl. Acad. Sci. USA. 2020;117:18591&#x2013;18599. doi: 10.1073/pnas.2005748117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2005748117</ArticleId><ArticleId IdType="pmc">PMC7414156</ArticleId><ArticleId IdType="pubmed">32690681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Raphael A.R., Ladow E.S., Mcgurk L., Weber R.A., Trojanowski J.Q., Lee V.M.Y., Finkbeiner S., Gitler A.D., Bonini N.M. Therapeutic modulation of eIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 2014;46:152&#x2013;160. doi: 10.1038/ng.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Cabuy E., Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 2009;12:627&#x2013;636. doi: 10.1038/nn.2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Medinas D.B., Rozas P., Mart&#xed;nez Traub F., Woehlbier U., Brown R.H., Bosco D.A., Hetz C. Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2018;115:8209&#x2013;8214. doi: 10.1073/pnas.1801109115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1801109115</ArticleId><ArticleId IdType="pmc">PMC6094144</ArticleId><ArticleId IdType="pubmed">30038021</ArticleId></ArticleIdList></Reference><Reference><Citation>Green K.M., Glineburg M.R., Kearse M.G., Flores B.N., Linsalata A.E., Fedak S.J., Goldstrohm A.C., Barmada S.J., Todd P.K. RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nat. Commun. 2017;8:s41467s017. doi: 10.1038/s41467-017-02200-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02200-0</ArticleId><ArticleId IdType="pmc">PMC5722904</ArticleId><ArticleId IdType="pubmed">29222490</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W., Wang S., Mestre A.A., Fu C., Makarem A., Xian F., Hayes L.R., Lopez-Gonzalez R., Drenner K., Jiang J., et al. C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2&#x3b1; phosphorylation. Nat. Commun. 2018;9:51. doi: 10.1038/s41467-017-02495-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02495-z</ArticleId><ArticleId IdType="pmc">PMC5754368</ArticleId><ArticleId IdType="pubmed">29302060</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Soo K.Y., Sundaramoorthy V., Parakh S., Ma Y., Farg M.A., Wallace R.H., Crouch P.J., Turner B.J., Horne M.K., et al. ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation. PLoS ONE. 2013;8:e81170. doi: 10.1371/journal.pone.0081170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081170</ArticleId><ArticleId IdType="pmc">PMC3843686</ArticleId><ArticleId IdType="pubmed">24312274</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., An H., Skelt L., Tregoning J.S., Humphreys I.R., Buchman V.L. Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis. Cell Rep. 2019;29:4496&#x2013;4508.e4. doi: 10.1016/j.celrep.2019.11.094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.11.094</ArticleId><ArticleId IdType="pmc">PMC6941233</ArticleId><ArticleId IdType="pubmed">31875556</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayalakshmi K., Alladi P.A., Ghosh S., Prasanna V.K., Sagar B.C., Nalini A., Sathyaprabha T.N., Raju T.R. Evidence of endoplasmic reticular stress in the spinal motor neurons exposed to CSF from sporadic amyotrophic lateral sclerosis patients. Neurobiol. Dis. 2011;41:695&#x2013;705. doi: 10.1016/j.nbd.2010.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.12.005</ArticleId><ArticleId IdType="pubmed">21168498</ArticleId></ArticleIdList></Reference><Reference><Citation>Axten J.M., Medina J.R., Feng Y., Shu A., Romeril S.P., Grant S.W., Li W.H., Heerding D.A., Minthorn E., Mencken T., et al. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-p yrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) J Med. Chem. 2012;55:7193&#x2013;7207. doi: 10.1021/jm300713s.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm300713s</ArticleId><ArticleId IdType="pubmed">22827572</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D., Kaufman R.J., Ma D., Coen D.M., Ron D., et al. A selective inhibitor of elF2&#x3b1; dephosphorylation protects cells from ER stress. Science. 2005;307:935&#x2013;939. doi: 10.1126/science.1101902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1101902</ArticleId><ArticleId IdType="pubmed">15705855</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsaytler P., Harding H.P., Ron D., Bertolotti A. Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science. 2011;332:91&#x2013;94. doi: 10.1126/science.1201396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1201396</ArticleId><ArticleId IdType="pubmed">21385720</ArticleId></ArticleIdList></Reference><Reference><Citation>Das I., Krzyzosiak A., Schneider K., Wrabetz L., D&#x2019;Antonio M., Barry N., Sigurdardottir A., Bertolotti A. Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science. 2015;348:239&#x2013;242. doi: 10.1126/science.aaa4484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa4484</ArticleId><ArticleId IdType="pmc">PMC4490275</ArticleId><ArticleId IdType="pubmed">25859045</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidrauski C., Acosta-Alvear D., Khoutorsky A., Vedantham P., Hearn B.R., Li H., Gamache K., Gallagher C.M., Ang K.K., Wilson C., et al. Pharmacological brake-release of mRNA translation enhances cognitive memory. eLife. 2013;2:e00498. doi: 10.7554/eLife.00498.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.00498</ArticleId><ArticleId IdType="pmc">PMC3667625</ArticleId><ArticleId IdType="pubmed">23741617</ArticleId></ArticleIdList></Reference><Reference><Citation>Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS.  [(accessed on 1 July 2022)].  Available online:  https://www.globenewswire.com/news-release/2021/09/09/2294411/0/en/Denali-Therapeutics-Announces-Initiation-of-Phase-1b-Study-of-EIF2B-Activator-DNL343-in-ALS.html.</Citation></Reference><Reference><Citation>A Phase 1 Study to Investigate the Safety and Pharmacokinetics of ABBV-CLS-7262 in Patients with Amyotrophic Lateral Sclerosis.  [(accessed on 1 July 2022)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT04948645.</Citation></Reference><Reference><Citation>Halliday M., Radford H., Zents K.A.M., Molloy C., Moreno J.A., Verity N.C., Smith E., Ortori C.A., Barrett D.A., Bushell M., et al. Repurposed drugs targeting eIF2&#x3b1;-P-mediated translational repression prevent neurodegeneration in mice. Brain. 2017;140:1768&#x2013;1783. doi: 10.1093/brain/awx074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx074</ArticleId><ArticleId IdType="pmc">PMC5445255</ArticleId><ArticleId IdType="pubmed">28430857</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri S., Kiaei M., Kipiani K., Chen J., Calingasan N.Y., Crow J.P., Beal M.F. Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2006;22:40&#x2013;49. doi: 10.1016/j.nbd.2005.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.09.013</ArticleId><ArticleId IdType="pubmed">16289867</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Signore S.J., Amante D.J., Kim J., Stack E.C., Goodrich S., Cormier K., Smith K., Cudkowicz M.E., Ferrante R.J. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotroph. Lateral Scler. 2009;10:85&#x2013;94. doi: 10.1080/17482960802226148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802226148</ArticleId><ArticleId IdType="pubmed">18618304</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Jansen-West K., Xu Y.F., Gendron T.F., Bieniek K.F., Lin W.L., Sasaguri H., Caulfield T., Hubbard J., Daughrity L., et al. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 2014;128:505&#x2013;524. doi: 10.1007/s00401-014-1336-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1336-5</ArticleId><ArticleId IdType="pmc">PMC4159567</ArticleId><ArticleId IdType="pubmed">25173361</ArticleId></ArticleIdList></Reference><Reference><Citation>Min J.H., Hong Y.H., Sung J.J., Kim S.M., Lee J.B., Lee K.W. Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: A randomized cross-over trial. J. Korean Med. Sci. 2012;27:200&#x2013;206. doi: 10.3346/jkms.2012.27.2.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2012.27.2.200</ArticleId><ArticleId IdType="pmc">PMC3271295</ArticleId><ArticleId IdType="pubmed">22323869</ArticleId></ArticleIdList></Reference><Reference><Citation>Novoa I., Zeng H., Harding H.P., Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J. Cell Biol. 2001;153:1011&#x2013;1022. doi: 10.1083/jcb.153.5.1011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.153.5.1011</ArticleId><ArticleId IdType="pmc">PMC2174339</ArticleId><ArticleId IdType="pubmed">11381086</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzhashiashvili Y., Monckton C.P., Shah H.S., Kunjamma R.B., Popko B. The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS. Neurobiol. Dis. 2019;127:527&#x2013;544. doi: 10.1016/j.nbd.2019.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.03.024</ArticleId><ArticleId IdType="pmc">PMC6588429</ArticleId><ArticleId IdType="pubmed">30923003</ArticleId></ArticleIdList></Reference><Reference><Citation>Matus S., Lopez E., Valenzuela V., Nassif M., Hetz C. Functional contribution of the transcription factor ATF4 to the pathogenesis of amyotrophic lateral sclerosis. PLoS ONE. 2013;8:e66672. doi: 10.1371/journal.pone.0066672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0066672</ArticleId><ArticleId IdType="pmc">PMC3715499</ArticleId><ArticleId IdType="pubmed">23874395</ArticleId></ArticleIdList></Reference><Reference><Citation>Seijffers R., Zhang J., Matthews J.C., Chen A., Tamrazian E., Babaniyi O., Selig M., Hynynen M., Woolf C.J., Brown R.H. ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation. Proc. Natl. Acad. Sci. USA. 2014;111:1622&#x2013;1627. doi: 10.1073/pnas.1314826111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314826111</ArticleId><ArticleId IdType="pmc">PMC3910594</ArticleId><ArticleId IdType="pubmed">24474789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Hernandez M., Tadokoro T., Navarro M.R., Platoshyn O., Kobayashi Y., Marsala S., Miyanohara A., Juhas S., Juhasova J., Skalnikova H., et al. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS. Nat. Med. 2020;26:118&#x2013;130. doi: 10.1038/s41591-019-0674-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0674-1</ArticleId><ArticleId IdType="pmc">PMC8171115</ArticleId><ArticleId IdType="pubmed">31873312</ArticleId></ArticleIdList></Reference><Reference><Citation>Matus S., Nassif M., Glimcher L.H., Hetz C. XBP-1 deficiency in the nervous system reveals a homeostatic switch to activate autophagy. Autophagy. 2009;5:1226&#x2013;1228. doi: 10.4161/auto.5.8.10247.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5.8.10247</ArticleId><ArticleId IdType="pubmed">19855189</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Popko B., Roos R.P. The unfolded protein response in familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 2011;20:1008&#x2013;1015. doi: 10.1093/hmg/ddq546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq546</ArticleId><ArticleId IdType="pmc">PMC3033190</ArticleId><ArticleId IdType="pubmed">21159797</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Popko B., Roos R.P. An enhanced integrated stress response ameliorates mutant SOD1-induced ALS. Hum. Mol. Genet. 2014;23:2629&#x2013;2638. doi: 10.1093/hmg/ddt658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt658</ArticleId><ArticleId IdType="pmc">PMC3990163</ArticleId><ArticleId IdType="pubmed">24368417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Popko B., Tixier E., Roos R.P. Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis. Neurobiol. Dis. 2014;71:317&#x2013;324. doi: 10.1016/j.nbd.2014.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.08.010</ArticleId><ArticleId IdType="pmc">PMC4179984</ArticleId><ArticleId IdType="pubmed">25134731</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H.Q., Ren M., Jiang H.Z., Wang J., Zhang J., Yin X., Wang S.Y., Qi Y., Wang X.D., Feng H.L. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neuroscience. 2014;277:132&#x2013;138. doi: 10.1016/j.neuroscience.2014.03.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.03.047</ArticleId><ArticleId IdType="pubmed">24699224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadge G.D., Sonobe Y., Camarena A., Drigotas C., Rigo F., Ling K.K., Roos R.P. Knockdown of GADD34 in neonatal mutant SOD1 mice ameliorates ALS. Neurobiol. Dis. 2020;136:104702. doi: 10.1016/j.nbd.2019.104702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104702</ArticleId><ArticleId IdType="pubmed">31837419</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira F.G., Ping Q., Moreno A.J., Kidd J.D., Thompson K., Jiang B., Lincecum J.M., Wang M.Z., De Zutter G.S., Tassinari V.R., et al. Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS. PLoS ONE. 2015;10:e0135570. doi: 10.1371/journal.pone.0135570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135570</ArticleId><ArticleId IdType="pmc">PMC4545826</ArticleId><ArticleId IdType="pubmed">26288094</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs D.I., Defensor E., Memar Ardestani P., Yi B., Halpain M., Seabrook G., Shamloo M. Role of Endoplasmic Reticulum Stress in Learning and Memory Impairment and Alzheimer&#x2019;s Disease-Like Neuropathology in the PS19 and APP(Swe) Mouse Models of Tauopathy and Amyloidosis. eNeuro. 2017;4:28721361. doi: 10.1523/ENEURO.0025-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0025-17.2017</ArticleId><ArticleId IdType="pmc">PMC5510086</ArticleId><ArticleId IdType="pubmed">28721361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Daigle J.G., Cunningham K.M., Coyne A.N., Ruan K., Grima J.C., Bowen K.E., Wadhwa H., Yang P., Rigo F., et al. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport. Cell. 2018;173:958&#x2013;971.e17. doi: 10.1016/j.cell.2018.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Belzil V.V., Batra R., Ross C.A., Gendron T.F., Pregent L.J., Murray M.E., Overstreet K.K., Piazza-Johnston A.E., Desaro P., et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 2015;18:1175&#x2013;1182. doi: 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonobe Y., Ghadge G., Masaki K., Sendoel A., Fuchs E., Roos R.P. Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress. Neurobiol. Dis. 2018;116:155&#x2013;165. doi: 10.1016/j.nbd.2018.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.05.009</ArticleId><ArticleId IdType="pmc">PMC6331062</ArticleId><ArticleId IdType="pubmed">29792928</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T., McAvoy K., Russell K., Wen X., Pang Y., Morris B., Pasinelli P., Trotti D., Haeusler A. Repeat-associated non- AUG translation in C9orf72- ALS / FTD is driven by neuronal excitation and stress. EMBO Mol. Med. 2019;11:e9423. doi: 10.15252/emmm.201809423.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201809423</ArticleId><ArticleId IdType="pmc">PMC6365928</ArticleId><ArticleId IdType="pubmed">30617154</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowley M.J., Diamantidis C.J., McDuffie J.R., Cameron B., Stanifer J., Mock C.K., Kosinski A., Wang X., Tang S., Williams J.W.J. Metformin Use in Patients with Historical Contraindications or Precautions. Department of Veterans Affairs; Washington, DC, USA: 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">28121088</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Lee V.M.Y., Trojanowski J.Q. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol. Med. 2011;17:659&#x2013;667. doi: 10.1016/j.molmed.2011.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2011.06.004</ArticleId><ArticleId IdType="pmc">PMC3202652</ArticleId><ArticleId IdType="pubmed">21783422</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010;19:R46&#x2013;R64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Takeda T., Shibata N., Kobayashi M. Alterations in subcellular localization of TDP-43 immunoreactivity in the anterior horns in sporadic amyotrophic lateral sclerosis. Neurosci. Lett. 2010;478:72&#x2013;76. doi: 10.1016/j.neulet.2010.04.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2010.04.068</ArticleId><ArticleId IdType="pubmed">20447446</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A., Velde C. Vande Alterations in stress granule dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS? Front. Cell. Neurosci. 2015;9:423. doi: 10.3389/fncel.2015.00423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00423</ArticleId><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>An H., Litscher G., Watanabe N., Wei W., Hashimoto T., Iwatsubo T., Buchman V.L., Shelkovnikova T.A. ALS-linked cytoplasmic FUS assemblies are compositionally different from physiological stress granules and sequester hnRNPA3, a novel modifier of FUS toxicity. Neurobiol. Dis. 2022;162:105585. doi: 10.1016/j.nbd.2021.105585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105585</ArticleId><ArticleId IdType="pmc">PMC8799889</ArticleId><ArticleId IdType="pubmed">34915152</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J., Tadokoro T., Baughn M.W., Myers B., McAlonis-Downes M., Chillon-Marinas C., Asiaban J.N., Artates J., Bui A.T., Vetto A.P., et al. ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS. Neuron. 2018;100:816&#x2013;830.e7. doi: 10.1016/j.neuron.2018.09.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.044</ArticleId><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Soo K.Y., Walker A.K., Pham H., Orian J., Horne M.K., Warraich S.T., Williams K.L., Blair I.P., Atkin J.D. Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfide-isomerase. Neurobiol. Aging. 2012;33:2855&#x2013;2868. doi: 10.1016/j.neurobiolaging.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.02.009</ArticleId><ArticleId IdType="pubmed">22459602</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo K.Y., Halloran M., Sundaramoorthy V., Parakh S., Toth R.P., Southam K.A., McLean C.A., Lock P., King A., Farg M.A., et al. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS. Acta Neuropathol. 2015;130:679&#x2013;697. doi: 10.1007/s00401-015-1468-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1468-2</ArticleId><ArticleId IdType="pubmed">26298469</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 2009;111:1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Bilgutay A., Zhang Y.-J., Vanderweyde T., Citro A., Mehta T., Zaarur N., McKee A., Bowser R., Sherman M., et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue. PLoS ONE. 2010;5:e13250. doi: 10.1371/journal.pone.0013250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C.M., Cenik B., Sephton C.F., Dries D.R., Mayer P., 3rd, Good S.K., Johnson B.A., Herz J., Yu G. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol. Cell. Biol. 2011;31:1098&#x2013;1108. doi: 10.1128/MCB.01279-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01279-10</ArticleId><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald K.K., Aulas A., Destroismaisons L., Pickles S., Beleac E., Camu W., Rouleau G.A., Velde C. Vande TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum. Mol. Genet. 2011;20:1400&#x2013;1410. doi: 10.1093/hmg/ddr021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr021</ArticleId><ArticleId IdType="pubmed">21257637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha N., Anderson P. Stress granules: Sites of mRNA triage that regulate mRNA stability and translatability. Biochem. Soc. Trans. 2002;30:963&#x2013;969. doi: 10.1042/bst0300963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0300963</ArticleId><ArticleId IdType="pubmed">12440955</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalfallah Y., Kuta R., Grasmuck C., Prat A., Durham H.D., Vande Velde C. TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci. Rep. 2018;8:7551. doi: 10.1038/s41598-018-25767-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25767-0</ArticleId><ArticleId IdType="pmc">PMC5953947</ArticleId><ArticleId IdType="pubmed">29765078</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla Bella E., Bersano E., Antonini G., Borghero G., Capasso M., Caponnetto C., Chi&#xf2; A., Corbo M., Filosto M., Giannini F., et al. The unfolded protein response in amyotrophic later sclerosis: Results of a phase 2 trial. Brain. 2021;144:2635&#x2013;2647. doi: 10.1093/brain/awab167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab167</ArticleId><ArticleId IdType="pmc">PMC8557337</ArticleId><ArticleId IdType="pubmed">33905493</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno J.A., Halliday M., Molloy C., Radford H., Verity N., Axten J.M., Ortori C.A., Willis A.E., Fischer P.M., Barrett D.A., et al. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med. 2013;5:206ra138. doi: 10.1126/scitranslmed.3006767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3006767</ArticleId><ArticleId IdType="pubmed">24107777</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliday M., Radford H., Sekine Y., Moreno J., Verity N., le Quesne J., Ortori C.A., Barrett D.A., Fromont C., Fischer P.M., et al. Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity. Cell. Death Dis. 2015;6:e1672. doi: 10.1038/cddis.2015.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.49</ArticleId><ArticleId IdType="pmc">PMC4385927</ArticleId><ArticleId IdType="pubmed">25741597</ArticleId></ArticleIdList></Reference><Reference><Citation>A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088.  [(accessed on 1 July 2022)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT03610334.</Citation></Reference><Reference><Citation>A Study to Evaluate the Bioavailability and Safety of DNL343 in Healthy Volunteers.  [(accessed on 1 July 2022)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT04581772?term=DNL343&amp;draw=2&amp;rank=3.</Citation></Reference><Reference><Citation>A Phase 1 Open-Label, Randomized, Crossover Study to Evaluate the Bioavailability, Effect of Food, Palatability, and Safety of Various DNL343 Oral Formulations in Healthy Participants.  [(accessed on 1 July 2022)]; Available online:  https://www.clinicaltrials.gov/ct2/show/NCT04581772.</Citation></Reference><Reference><Citation>A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants with Amyotrophic Lateral Sclerosis.  [(accessed on 1 July 2022)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT05006352?term=DNL343&amp;draw=2&amp;rank=2.</Citation></Reference><Reference><Citation>Denali Therapeutics Announces Positive Clinical Results and Regulatory Progress for Development Programs in Amyotrophic Lateral Sclerosis (ALS)  [(accessed on 1 July 2022)]; Available online:  https://www.globenewswire.com/news-release/2021/10/06/2309876/0/en/Denali-Therapeutics-Announces-Positive-Clinical-Results-and-Regulatory-Progress-for-Development-Programs-in-Amyotrophic-Lateral-Sclerosis-ALS.html.</Citation></Reference><Reference><Citation>Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD.  [(accessed on 1 July 2022)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT04220021.</Citation></Reference><Reference><Citation>Delaye J.B., Lanznaster D., Veyrat-Durebex C., Fontaine A., Bacle G., Lefevre A., Hergesheimer R., Lecron J.C., Vourc&#x2019;h P., Andres C.R., et al. Behavioral, Hormonal, Inflammatory, and Metabolic Effects Associated with FGF21-Pathway Activation in an ALS Mouse Model. Neurother. J. Am. Soc. Exp. Neurother. 2020;18:297&#x2013;308. doi: 10.1007/s13311-020-00933-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-020-00933-3</ArticleId><ArticleId IdType="pmc">PMC8116478</ArticleId><ArticleId IdType="pubmed">33021723</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams C.M., Ebert S.M., Dyle M.C. Role of ATF4 in skeletal muscle atrophy. Curr. Opin. Clin. Nutr. Metab. Care. 2017;20:164&#x2013;168. doi: 10.1097/MCO.0000000000000362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000362</ArticleId><ArticleId IdType="pubmed">28376050</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Zhu M., Zhang Y., Diao Y. Crossing the blood-brain barrier with AAV vectors. Metab. Brain Dis. 2021;36:45&#x2013;52. doi: 10.1007/s11011-020-00630-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-020-00630-2</ArticleId><ArticleId IdType="pubmed">33201426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>